Quoin Pharmaceuticals Ltd. SEC filings QNRX

Quoin Pharmaceuticals Ltd. has 583 filings in SEC EDGAR's recent list, going back to Apr 8, 2016. Its latest annual report, Form ARS, was filed on Jul 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement).

Quoin Pharmaceuticals Ltd. SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Nov 4, 2026 Nov 4, 2026
8-K Current report
Regulation FD disclosure, Other events
Oct 20, 2026 Oct 20, 2026
8-K Current report
Regulation FD disclosure, Other events
Oct 14, 2026 Oct 14, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 22, 2026 Sep 22, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 10, 2026 Sep 8, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Aug 28, 2026 Aug 27, 2026
8-K Current report
Officer or director change, Shareholder vote results, Other events
Aug 20, 2026 Aug 20, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 23, 2026 Jun 23, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 4, 2026 Jun 4, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
8-K Current report
Results of operations
Mar 26, 2026 Mar 26, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 11, 2026 Mar 11, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 20, 2026 Jan 20, 2026
8-K Current report
Officer or director change
Nov 17, 2025 Nov 14, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 12, 2025 Nov 11, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 21, 2025 Oct 21, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 15, 2025 Oct 10, 2025
8-K Current report
Officer or director change
Aug 27, 2025 Aug 21, 2025
8-K Current report
Change to shareholder rights, Officer or director change, Shareholder vote results, Regulation FD disclosure, Other events
Aug 21, 2025 Aug 15, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Officer or director change
Jul 8, 2025 Jul 3, 2025
8-K Current report
Other events
Jun 25, 2025 Jun 24, 2025
8-K Current report
Other events
Jun 20, 2025 Jun 18, 2025
8-K Current report
Officer or director change
Jun 4, 2025 May 29, 2025
8-K Current report
Other events
May 23, 2025 May 22, 2025
8-K Current report
Other events
May 21, 2025 May 20, 2025
8-K Current report
Results of operations
May 14, 2025 May 13, 2025
8-K Current report
Other events
Apr 30, 2025 Apr 29, 2025
8-K Current report
Change to shareholder rights
Apr 4, 2025 Apr 4, 2025
8-K Current report
Change to shareholder rights
Apr 4, 2025 Apr 4, 2025
8-K Current report
Other events
Apr 2, 2025 Apr 2, 2025
8-K Current report
Auditor change
Mar 20, 2025 Mar 18, 2025
8-K Current report
Results of operations
Mar 13, 2025 Mar 13, 2025
8-K Current report
Other events
Feb 27, 2025 Feb 27, 2025
8-K Current report
Other events
Feb 4, 2025 Feb 4, 2025
8-K Current report
Other events
Jan 23, 2025 Jan 23, 2025
8-K Current report
Other events
Jan 16, 2025 Jan 14, 2025
8-K Current report
Other events
Jan 6, 2025 Jan 6, 2025
8-K Current report
Material agreement, Other events
Dec 26, 2024 Dec 20, 2024
8-K Current report
Other events
Dec 19, 2024 Dec 19, 2024
8-K Current report
Change to shareholder rights, Officer or director change, Shareholder vote results, Other events
Dec 10, 2024 Dec 5, 2024
8-K Current report
Results of operations
Nov 8, 2024 Nov 7, 2024
8-K Current report
Listing notice
Oct 31, 2024 Oct 29, 2024
8-K Current report
Other events
Sep 30, 2024 Sep 27, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 8, 2024
8-K Current report
Listing notice
May 3, 2024 Apr 29, 2024
8-K Current report
Shareholder vote results
Apr 9, 2024 Apr 5, 2024
8-K Current report
Results of operations
Mar 13, 2024 Mar 13, 2024
8-K Current report
Material agreement, Other events
Mar 8, 2024 Mar 4, 2024
8-K Current report
Other events
Mar 6, 2024 Feb 29, 2024
8-K Current report
Material agreement, Unregistered share sale
Jan 30, 2024 Jan 25, 2024
8-K Current report
Other events
Dec 18, 2023 Dec 13, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 8, 2023
8-K Current report
Change to shareholder rights, Shareholder vote results
Nov 6, 2023 Nov 5, 2023
8-K Current report
Officer or director change, Shareholder vote results, Other events
Nov 1, 2023 Oct 26, 2023
8-K Current report
Material agreement
Sep 13, 2023 Sep 6, 2023
8-K Current report
Results of operations, Other events
Aug 2, 2023 Aug 2, 2023
8-K/A Amended current report
Change to shareholder rights
Jul 14, 2023 Jun 22, 2023
8-K Current report
Change to shareholder rights
Jun 28, 2023 Jun 22, 2023
8-K Current report
Other events
May 12, 2023 May 9, 2023
8-K Current report
Results of operations
May 8, 2023 May 8, 2023
8-K Current report
Listing notice
Apr 7, 2023 Apr 5, 2023
8-K Current report
Results of operations
Mar 9, 2023 Mar 8, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Feb 28, 2023 Feb 22, 2023
6-K Current report (foreign issuer) Nov 10, 2022 Sep 30, 2022
6-K Current report (foreign issuer) Nov 7, 2022 Nov 7, 2022
6-K Current report (foreign issuer) Oct 28, 2022 Oct 27, 2022
6-K Current report (foreign issuer) Sep 21, 2022 Sep 21, 2022
6-K Current report (foreign issuer) Aug 18, 2022 Jun 30, 2022
6-K Current report (foreign issuer) Aug 11, 2022 Aug 10, 2022
6-K Current report (foreign issuer) Jul 15, 2022 Jul 15, 2022
6-K Current report (foreign issuer) Jun 17, 2022 Jun 16, 2022
6-K Current report (foreign issuer) Jun 13, 2022 Jun 13, 2022
6-K Current report (foreign issuer) Jun 6, 2022 Jun 6, 2022
6-K Current report (foreign issuer) May 23, 2022 May 23, 2022
6-K Current report (foreign issuer) Apr 28, 2022 Apr 28, 2022
6-K Current report (foreign issuer) Apr 13, 2022 Apr 13, 2022
6-K Current report (foreign issuer) Mar 28, 2022 Mar 28, 2022
6-K Current report (foreign issuer) Mar 8, 2022 Mar 8, 2022
6-K Current report (foreign issuer) Feb 8, 2022 Feb 7, 2022
6-K Current report (foreign issuer) Jan 31, 2022 Jan 31, 2022
6-K Current report (foreign issuer) Jan 12, 2022 Jan 11, 2022
6-K Current report (foreign issuer) Dec 20, 2021 Dec 17, 2021
6-K Current report (foreign issuer) Nov 23, 2021 Nov 23, 2021
6-K Current report (foreign issuer) Oct 29, 2021 Oct 28, 2021
6-K Current report (foreign issuer) Oct 15, 2021 Oct 15, 2021
6-K Current report (foreign issuer) Sep 27, 2021 Sep 27, 2021
6-K Current report (foreign issuer) Sep 20, 2021 Sep 20, 2021
6-K Current report (foreign issuer) Sep 17, 2021 Sep 17, 2021
6-K Current report (foreign issuer) Sep 10, 2021 Sep 10, 2021
6-K Current report (foreign issuer) Sep 2, 2021 Sep 2, 2021
6-K Current report (foreign issuer) Aug 24, 2021 Jun 30, 2021
6-K Current report (foreign issuer) Aug 13, 2021 Aug 13, 2021
6-K Current report (foreign issuer) Jun 17, 2021 Jun 16, 2021
6-K Current report (foreign issuer) Jun 3, 2021 Jun 3, 2021
6-K Current report (foreign issuer) Apr 19, 2021 Apr 19, 2021
6-K Current report (foreign issuer) Mar 29, 2021 Mar 29, 2021
6-K Current report (foreign issuer) Mar 24, 2021 Mar 24, 2021
6-K/A Amendment no. 1 to form 6-k Feb 11, 2021 Jun 30, 2020
6-K Current report (foreign issuer) Nov 20, 2020 Nov 20, 2020
6-K Current report (foreign issuer) Nov 9, 2020 Nov 9, 2020
6-K Current report (foreign issuer) Nov 2, 2020 Nov 1, 2020
6-K Current report (foreign issuer) Oct 29, 2020 Oct 29, 2020
6-K Current report (foreign issuer) Oct 22, 2020 Oct 22, 2020
6-K Current report (foreign issuer) Oct 20, 2020 Oct 20, 2020
6-K Current report (foreign issuer) Oct 13, 2020 Oct 13, 2020
6-K Current report (foreign issuer) Sep 25, 2020 Sep 25, 2020
6-K Current report (foreign issuer) Sep 21, 2020 Sep 21, 2020
6-K Current report (foreign issuer) Aug 12, 2020 Aug 12, 2020
6-K Current report (foreign issuer) Aug 6, 2020 Aug 6, 2020
6-K Current report (foreign issuer) Jun 3, 2020 Jun 3, 2020
6-K Current report (foreign issuer) May 27, 2020 May 27, 2020
6-K Current report (foreign issuer) May 21, 2020 May 21, 2020
6-K Current report (foreign issuer) May 18, 2020 May 18, 2020
6-K Current report (foreign issuer) May 12, 2020 May 12, 2020
6-K Current report (foreign issuer) May 11, 2020 May 11, 2020
6-K Current report (foreign issuer) Apr 27, 2020 Apr 27, 2020
6-K Current report (foreign issuer) Apr 22, 2020 Apr 22, 2020
6-K Current report (foreign issuer) Apr 3, 2020 Apr 3, 2020
6-K Current report (foreign issuer) Apr 2, 2020 Apr 2, 2020
6-K Current report (foreign issuer) Mar 4, 2020 Mar 3, 2020
6-K Current report (foreign issuer) Jan 27, 2020 Jan 27, 2020
6-K Current report (foreign issuer) Jan 10, 2020 Jan 10, 2020
6-K Current report (foreign issuer) Jan 10, 2020 Jan 9, 2020
6-K Current report (foreign issuer) Jan 8, 2020 Jan 8, 2020
6-K Current report (foreign issuer) Jan 7, 2020 Jan 7, 2020
6-K Current report (foreign issuer) Jan 6, 2020 Jan 6, 2020
6-K Current report (foreign issuer) Dec 30, 2019 Dec 30, 2019
6-K Current report (foreign issuer) Dec 23, 2019 Dec 23, 2019
6-K Current report (foreign issuer) Nov 25, 2019 Nov 25, 2019
6-K Current report (foreign issuer) Nov 19, 2019 Nov 19, 2019
6-K Current report (foreign issuer) Nov 7, 2019 Nov 7, 2019
6-K Current report (foreign issuer) Nov 6, 2019 Nov 6, 2019
6-K Current report (foreign issuer) Oct 7, 2019 Oct 7, 2019
6-K Current report (foreign issuer) Aug 22, 2019 Aug 22, 2019
6-K Current report (foreign issuer) Aug 13, 2019 Jun 30, 2019
6-K Current report (foreign issuer) Aug 12, 2019 Aug 12, 2019
6-K Current report (foreign issuer) Aug 6, 2019 Aug 6, 2019
6-K Current report (foreign issuer) Jul 30, 2019 Jul 30, 2019
6-K Current report (foreign issuer) Jul 8, 2019 Jul 8, 2019
6-K Current report (foreign issuer) Jun 25, 2019 Jun 25, 2019
6-K Current report (foreign issuer) Jun 6, 2019 Jun 6, 2019
6-K Current report (foreign issuer) May 21, 2019 May 21, 2019
6-K Current report (foreign issuer) May 16, 2019 May 16, 2019
6-K Current report (foreign issuer) Apr 30, 2019 Apr 30, 2019
6-K Current report (foreign issuer) Mar 27, 2019 Mar 27, 2019
6-K Current report (foreign issuer) Mar 22, 2019 Mar 22, 2019
6-K Current report (foreign issuer) Mar 18, 2019 Mar 18, 2019
6-K Current report (foreign issuer) Mar 11, 2019 Mar 11, 2019
6-K Current report (foreign issuer) Feb 13, 2019 Feb 13, 2019
6-K Current report (foreign issuer) Feb 8, 2019 Feb 8, 2019
6-K Current report (foreign issuer) Feb 5, 2019 Feb 5, 2019
6-K Current report (foreign issuer) Jan 28, 2019 Jan 28, 2019
6-K Current report (foreign issuer) Jan 24, 2019 Jan 24, 2019
6-K Current report (foreign issuer) Jan 23, 2019 Jan 23, 2019
6-K Current report (foreign issuer) Dec 17, 2018 Dec 13, 2018
6-K Current report (foreign issuer) Nov 13, 2018 Nov 13, 2018
6-K Current report (foreign issuer) Nov 5, 2018 Nov 5, 2018
6-K Current report (foreign issuer) Oct 25, 2018 Oct 25, 2018
6-K Current report (foreign issuer) Oct 22, 2018 Oct 22, 2018
6-K Current report (foreign issuer) Oct 18, 2018 Oct 18, 2018
6-K Current report (foreign issuer) Oct 15, 2018 Oct 15, 2018
6-K Current report (foreign issuer) Sep 20, 2018 Sep 20, 2018
6-K Current report (foreign issuer) Sep 5, 2018 Sep 5, 2018
6-K Current report (foreign issuer) Aug 30, 2018 Aug 30, 2018
6-K Current report (foreign issuer) Aug 20, 2018 Aug 20, 2018
6-K Current report (foreign issuer) Aug 13, 2018 Aug 13, 2018
6-K Current report (foreign issuer) Aug 9, 2018 Aug 9, 2018
6-K Current report (foreign issuer) Aug 7, 2018 Aug 7, 2018
6-K Current report (foreign issuer) Jul 25, 2018 Jul 25, 2018
6-K Current report (foreign issuer) Jul 9, 2018 Jul 9, 2018
6-K Current report (foreign issuer) Jul 6, 2018 Jul 6, 2018
6-K Current report (foreign issuer) Jul 5, 2018 Jul 5, 2018
6-K Current report (foreign issuer) Jun 28, 2018 Jun 28, 2018
6-K Current report (foreign issuer) May 24, 2018 May 24, 2018
6-K Current report (foreign issuer) May 17, 2018 May 17, 2018
6-K Current report (foreign issuer) May 10, 2018 May 9, 2018
6-K Current report (foreign issuer) Apr 9, 2018 Apr 9, 2018
6-K Current report (foreign issuer) Mar 19, 2018 Mar 19, 2018
6-K Current report (foreign issuer) Jan 31, 2018 Jan 31, 2018
6-K Current report (foreign issuer) Jan 29, 2018 Jan 29, 2018
6-K Current report (foreign issuer) Jan 16, 2018 Jan 16, 2018
6-K Current report (foreign issuer) Jan 4, 2018 Jan 4, 2018
6-K Current report (foreign issuer) Dec 14, 2017 Dec 13, 2017
6-K/A Amendment no. 1 to form 6-k Nov 28, 2017 Nov 28, 2017
6-K Current report (foreign issuer) Nov 22, 2017 Nov 22, 2017
6-K Current report (foreign issuer) Nov 7, 2017 Nov 7, 2017
6-K Current report (foreign issuer) Nov 2, 2017 Nov 2, 2017
6-K Current report (foreign issuer) Oct 25, 2017 Oct 25, 2017
6-K Current report (foreign issuer) Oct 19, 2017 Oct 19, 2017
6-K Current report (foreign issuer) Sep 8, 2017 Sep 7, 2017
6-K Current report (foreign issuer) Sep 5, 2017 Sep 5, 2017
6-K Current report (foreign issuer) Aug 21, 2017 Aug 21, 2017
6-K Current report (foreign issuer) Aug 1, 2017 Aug 1, 2017
6-K Current report (foreign issuer) Jun 26, 2017 Jun 26, 2017
6-K Current report (foreign issuer) Jun 26, 2017 Jun 26, 2017
6-K Current report (foreign issuer) Jun 14, 2017 Jun 14, 2017
6-K Current report (foreign issuer) Jun 12, 2017 Jun 12, 2017

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
QNRX (Nasdaq)
Incorporated in
Israel
Headquarters
Ashburn, VA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1671502
Former names
Quoin Pharmaceuticals, Ltd. (until Sep 1, 2026); Cellect Biotechnology Ltd. (until Oct 15, 2021); Cellect Biomed Ltd. (until Jul 7, 2016)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.